84 related articles for article (PubMed ID: 20206607)
21. Osteoimmunomodulatory properties of magnesium scaffolds coated with β-tricalcium phosphate.
Chen Z; Mao X; Tan L; Friis T; Wu C; Crawford R; Xiao Y
Biomaterials; 2014 Oct; 35(30):8553-65. PubMed ID: 25017094
[TBL] [Abstract][Full Text] [Related]
22. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
[TBL] [Abstract][Full Text] [Related]
23. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
[TBL] [Abstract][Full Text] [Related]
24. [In vitro osteogenesis of the compound of chitosan and recombinant human bone morphogenetic protein 2].
Liang D; Zuo A; Wang B; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Sep; 19(9):721-4. PubMed ID: 16206761
[TBL] [Abstract][Full Text] [Related]
25. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
26. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
Kamitakahara M; Ohtsuki C; Miyazaki T
J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
28. The effect of bioactive glass ceramics on the expression of bone-related genes and proteins in vitro.
Knabe C; Stiller M; Berger G; Reif D; Gildenhaar R; Howlett CR; Zreiqat H
Clin Oral Implants Res; 2005 Feb; 16(1):119-27. PubMed ID: 15642039
[TBL] [Abstract][Full Text] [Related]
29. Potential induction of bone regeneration by nacre: an in vitro study.
Asvanund P; Chunhabundit P; Suddhasthira T
Implant Dent; 2011 Feb; 20(1):32-9. PubMed ID: 21278525
[TBL] [Abstract][Full Text] [Related]
30. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
Abarrategi A; Moreno-Vicente C; Ramos V; Aranaz I; Sanz Casado JV; López-Lacomba JL
Tissue Eng Part A; 2008 Aug; 14(8):1305-19. PubMed ID: 18491953
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
32. Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a pilot study in the Goettingen miniature pig comparing autogenous bone and rhGDF-5.
Gruber RM; Ludwig A; Merten HA; Pippig S; Kramer FJ; Schliephake H
Clin Oral Implants Res; 2009 Feb; 20(2):175-82. PubMed ID: 19077151
[TBL] [Abstract][Full Text] [Related]
33. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.
Tsai TT; Guttapalli A; Agrawal A; Albert TJ; Shapiro IM; Risbud MV
J Bone Miner Res; 2007 Jul; 22(7):965-74. PubMed ID: 17371162
[TBL] [Abstract][Full Text] [Related]
34. Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
Tao ZS; Zhou WS; Xu HG; Yang M
Biomed Pharmacother; 2020 Dec; 132():110911. PubMed ID: 33125972
[TBL] [Abstract][Full Text] [Related]
35. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study.
Kasten P; Beyen I; Niemeyer P; Luginbühl R; Bohner M; Richter W
Acta Biomater; 2008 Nov; 4(6):1904-15. PubMed ID: 18571999
[TBL] [Abstract][Full Text] [Related]
36. Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation.
Zerbo IR; Bronckers AL; de Lange G; Burger EH
Biomaterials; 2005 Apr; 26(12):1445-51. PubMed ID: 15482833
[TBL] [Abstract][Full Text] [Related]
37. Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.
Han D; Sun X; Zhang X; Tang T; Dai K
Connect Tissue Res; 2008; 49(5):343-50. PubMed ID: 18991087
[TBL] [Abstract][Full Text] [Related]
38. [An experimental study on repairing bone defect with composite of beta-tricalcium phosphate-hyaluronic acid-type I collagen-marrow stromal cells].
Wei A; Liu S; Peng H; Tao H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jun; 19(6):468-72. PubMed ID: 16038466
[TBL] [Abstract][Full Text] [Related]
39. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
[TBL] [Abstract][Full Text] [Related]
40. MBG-Modified β-TCP Scaffold Promotes Mesenchymal Stem Cells Adhesion and Osteogenic Differentiation via a FAK/MAPK Signaling Pathway.
Liu Y; Ma Y; Zhang J; Xie Q; Wang Z; Yu S; Yuan Y; Liu C
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30283-30296. PubMed ID: 28820575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]